DE60118859D1 - Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung - Google Patents

Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung

Info

Publication number
DE60118859D1
DE60118859D1 DE60118859T DE60118859T DE60118859D1 DE 60118859 D1 DE60118859 D1 DE 60118859D1 DE 60118859 T DE60118859 T DE 60118859T DE 60118859 T DE60118859 T DE 60118859T DE 60118859 D1 DE60118859 D1 DE 60118859D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
composition containing
ophthalmic use
containing trehalose
trehalose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60118859T
Other languages
English (en)
Other versions
DE60118859T2 (de
Inventor
Toshihiko Matsuo
Masashi Kurimoto
Hiroshi Yamauchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE60118859D1 publication Critical patent/DE60118859D1/de
Publication of DE60118859T2 publication Critical patent/DE60118859T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
DE60118859T 2000-09-14 2001-08-30 Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung Expired - Lifetime DE60118859T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000280023 2000-09-14
JP2000280023 2000-09-14

Publications (2)

Publication Number Publication Date
DE60118859D1 true DE60118859D1 (de) 2006-05-24
DE60118859T2 DE60118859T2 (de) 2006-11-23

Family

ID=18764933

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60138495T Expired - Lifetime DE60138495D1 (de) 2000-09-14 2001-08-30 Pharmazeutische Zusammensetzung Trehalose zur ophthalmischen Verwendung enthaltend
DE60118859T Expired - Lifetime DE60118859T2 (de) 2000-09-14 2001-08-30 Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60138495T Expired - Lifetime DE60138495D1 (de) 2000-09-14 2001-08-30 Pharmazeutische Zusammensetzung Trehalose zur ophthalmischen Verwendung enthaltend

Country Status (7)

Country Link
US (2) US6555526B2 (de)
EP (2) EP1649860B1 (de)
KR (1) KR100776124B1 (de)
AU (1) AU781975B2 (de)
CA (1) CA2355814C (de)
DE (2) DE60138495D1 (de)
TW (1) TWI291350B (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4397142B2 (ja) * 2001-11-20 2010-01-13 株式会社林原生物化学研究所 活性酸素消去能低減抑制剤
US20050065030A1 (en) * 2001-11-20 2005-03-24 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reduction inhibitory agent for active oxygen eliminating activity
NZ535323A (en) 2002-02-25 2008-02-29 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
US7759506B2 (en) 2002-02-25 2010-07-20 Diffusion Pharmaceuticals Llc Bipolar trans carotenoid salts and their uses
JP2005008596A (ja) * 2003-06-20 2005-01-13 Kobayashi Pharmaceut Co Ltd 眼科用組成物
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
CA2597525A1 (en) * 2005-02-17 2006-08-24 Senju Pharmaceutical Co., Ltd. Solid ophthalmic drug for external use
EP2540696B1 (de) 2005-02-24 2020-01-01 Diffusion Pharmaceuticals LLC Trans-Karotinoide, deren Formulierung und Verwendung
US8288348B2 (en) * 2005-07-13 2012-10-16 Allergan, Inc. Cyclosporin compositions
US7976833B2 (en) * 2005-10-14 2011-07-12 Aspen Biomedical Research, Llc Ophthalmic surgical irrigating solutions containing hyaluronidase and method for preventing post-operative intraocular pressure increases
US20070207116A1 (en) * 2006-03-01 2007-09-06 Brown David C Antioxidant compositions for the eye
US9539202B2 (en) * 2006-04-28 2017-01-10 Universidad Complutense De Madrid Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
JP4668875B2 (ja) * 2006-09-20 2011-04-13 株式会社日立製作所 番組録画再生装置、番組再生位置制御方法及び番組情報提供装置
MX2009010988A (es) * 2007-04-13 2010-03-15 Diffusion Pharmaceuticals Llc Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica.
JP2011502125A (ja) * 2007-10-31 2011-01-20 ディフュージョン・ファーマシューティカルズ・エルエルシー 小分子拡散を促進する新しい種類の治療法
EP2389069A1 (de) * 2009-01-20 2011-11-30 Advanced Vision Research, Inc. Verfahren und zusammensetzungen zur behandlung und prävention von infektionen
CA2765697C (en) * 2009-06-22 2019-11-12 Diffusion Pharmaceuticals Llc Diffusion enhancing compounds and their use alone or with thrombolytics
AU2011262361A1 (en) 2010-06-02 2013-01-10 Diffusion Pharmaceuticals Llc Oral formulations of bipolar trans carotenoids
US8957048B2 (en) 2011-10-06 2015-02-17 Allergan, Inc. Compositions for the treatment of dry eye
US9314528B2 (en) 2011-12-07 2016-04-19 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
JP6195848B2 (ja) 2012-01-27 2017-09-13 ザ、リージェンツ、オブ、ザ、ユニバーシティ、オブ、カリフォルニアＴｈｅ Ｒｅｇｅｎｔｓ Ｏｆ Ｔｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃａｌｉｆｏｒｎｉａ 糖ポリマーを用いた生体分子の安定化
WO2014081969A1 (en) * 2012-11-21 2014-05-30 University Of Louisville Research Foundation, Inc Compositions and methods for reducing oxidative damage
JP6837835B2 (ja) 2013-05-07 2021-03-03 バイオ・ブラスト・ファーマ・リミテッドＢｉｏ Ｂｌａｓｔ Ｐｈａｒｍａ Ｌｔｄ． トレハロースの非経口投与によるタンパク質凝集ミオパシーおよび神経変性疾患の治療
US9084720B2 (en) 2013-05-07 2015-07-21 BioBlast Pharma Ltd. Compositions and methods for treating oculopharyngeal muscular dystrophy
US9180208B2 (en) * 2013-09-25 2015-11-10 i SONIC Medical Corporation Composition and methods for enhancing surface reflectance
US10350232B1 (en) * 2013-11-04 2019-07-16 Peter D. Jaillet Medicinal drops
KR101587412B1 (ko) * 2014-10-17 2016-01-21 주식회사 휴온스 사이클로스포린 및 트레할로스를 포함하는 안과용 조성물
NZ732058A (en) 2014-11-25 2023-06-30 Allergan Inc Stabilized omega-3 ophthalmic compositions
CA3014030C (en) 2015-02-09 2023-10-03 Ori Braun Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
CN115089569A (zh) 2016-03-24 2022-09-23 扩散药品有限公司 双极性反式类胡萝卜素连同化疗和放射治疗在治疗癌症中的用途
KR102268319B1 (ko) * 2016-12-29 2021-06-23 (주)휴온스 지속성 점안제 조성물
EP3996671A1 (de) 2019-07-12 2022-05-18 Pharmathen S.A. Konservierungsmittelfreie pharmazeutische zusammensetzung mit cyclosporin zur ophthalmischen verabreichung
GR1010012B (el) 2020-05-12 2021-05-27 Φαρματεν Α.Β.Ε.Ε. Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3082094B2 (ja) 1990-11-15 2000-08-28 株式会社林原生物化学研究所 ネオトレハロースの製造方法とその用途
EP0691344B1 (de) 1992-12-28 2003-03-19 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Reinigung von Trehalose
JP3418423B2 (ja) * 1993-03-03 2003-06-23 久光製薬株式会社 経粘膜投与用薬剤組成物
JP3559585B2 (ja) 1993-06-03 2004-09-02 株式会社林原生物化学研究所 トレハロース遊離酵素とその製造方法並びに用途
US5871993A (en) 1994-02-23 1999-02-16 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo DNA encoding enzyme, recombinant DNA and enzyme, transformant, and their preparations and uses
JP3557272B2 (ja) 1994-02-23 2004-08-25 株式会社林原生物化学研究所 組換え型酵素とその製造方法並びに用途
DE69532485T2 (de) 1994-03-07 2004-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Trehalose-freisetzendes Enzym, dafür kodierende DNA, Herstellung und Verwendung
JP3559609B2 (ja) 1994-03-07 2004-09-02 株式会社林原生物化学研究所 組換え型酵素とその製造方法並びに用途
JP3557277B2 (ja) 1994-06-25 2004-08-25 株式会社林原生物化学研究所 耐熱性トレハロース遊離酵素とその製造方法並びに用途
AU695080B2 (en) 1994-06-24 1998-08-06 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Thermostable non-reducing saccharide-forming enzyme, its production and uses
JP3557287B2 (ja) 1994-06-24 2004-08-25 株式会社林原生物化学研究所 耐熱性非還元性糖質生成酵素とその製造方法並びに用途
JP3557288B2 (ja) 1994-07-21 2004-08-25 株式会社林原生物化学研究所 還元性澱粉糖から末端にトレハロース構造を有する非還元性糖質を生成する組換え型耐熱性酵素
JP3557289B2 (ja) 1994-07-21 2004-08-25 株式会社林原生物化学研究所 非還元性糖質からトレハロースを遊離する組換え型耐熱性酵素
JP4033510B2 (ja) * 1995-12-27 2008-01-16 ロート製薬株式会社 トレハロースを含有する眼科用医薬組成物
AU1172097A (en) * 1995-12-27 1997-07-28 Rohto Pharmaceutical Co., Ltd. Pharmaceutical composition containing trehalose
JPH09227385A (ja) * 1996-02-29 1997-09-02 Ofutekusu:Kk 眼手術用補助剤
JPH1072376A (ja) * 1996-09-02 1998-03-17 Ofutekusu:Kk ヒアルロン酸含有点眼水溶液
JP4203159B2 (ja) * 1997-12-09 2008-12-24 株式会社林原生物化学研究所 神経機能調節剤
CA2405099A1 (en) * 2000-04-04 2001-10-11 Amarillo Biosciences, Inc. Composition and method for promoting oral health

Also Published As

Publication number Publication date
US7732425B2 (en) 2010-06-08
CA2355814C (en) 2010-06-29
DE60118859T2 (de) 2006-11-23
TWI291350B (en) 2007-12-21
US6555526B2 (en) 2003-04-29
CA2355814A1 (en) 2002-03-14
US20020055486A1 (en) 2002-05-09
KR20020021320A (ko) 2002-03-20
EP1649860A1 (de) 2006-04-26
DE60138495D1 (de) 2009-06-04
AU6545301A (en) 2002-03-21
AU781975B2 (en) 2005-06-23
EP1192947A1 (de) 2002-04-03
EP1649860B1 (de) 2009-04-22
KR100776124B1 (ko) 2007-11-15
EP1192947B1 (de) 2006-04-19
US20030186931A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
DE60118859D1 (de) Pharmazeutische Zusammensetzung enthaltend Trehalose zur ophthalmischen Verwendung
ATE355271T1 (de) Pharmazeutische zusammensetzung
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
ATA1292000A (de) Pharmazeutische zusammensetzung zur immunmodulation und herstellung von vakzinen
ATE334656T1 (de) Flüssige pharmazeutische zusammensetzung
DE60111769D1 (de) Flüssige pharmazeutische formulierungen mit verbesserter oraler veträglichkeit
ATE320244T1 (de) Pharmazeutische zusammensetzungen mit amlodipinmaleat
ATE307571T1 (de) Pharmazeutische formulierung enthaltend bicalutamid
ATE392863T1 (de) Streifen zur abgabe eines mundpflegewirkstoffes
ATE317260T1 (de) Pharmazeutische formulierungen mit platinderivaten
FR2815535B1 (fr) Implant pediculaire
ATE292960T1 (de) Pharmazeutische zubereitung zur anwendung in der antiasthmatherapie
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
DE50111900D1 (de) Medizinisches implantat
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
ATE477814T1 (de) Stabile faktor-viii enthaltende pharmazeutische zusammensetzung
EE05439B1 (et) Ketotifeeni sisaldav oftalmiline ravimkoostis
ATE324883T1 (de) Pharmazeutische zusammensetzung enthaltend lumiracoxib
DE60119354D1 (de) Spritze zur Dentalanästhesie
ATE350016T1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
DE60129238D1 (de) Pharmazeutische zusammensetzung
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida

Legal Events

Date Code Title Description
8364 No opposition during term of opposition